Investigators assessed whether daily bathing with 2% chlorhexidine gluconate decreases the risk for vancomycin-resistant enterococci (VRE) transmission in an intensive care unit with increased VRE endemicity.
Investigators conducted a study to assess the incidence and risk factors associated with infective endocarditis in patients with and without active cancer.
Researchers conducted a study that compared mortality outcomes between first-line antibiotic therapy with a -lactam agent vs vancomycin among patients hospitalized with a bloodstream infection.
Researchers conducted a study to assess whether covering high-touch surfaces with a foil containing an integrated silver-based agent decreases the risk for hospital-acquired infections.
Researchers conducted a study to assess the effects of vancomycin plus ceftaroline for the treatment of patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Researchers sought to determine whether there is a correlation between antimicrobial-resistant pathogens and influenza infection rates that occur during influenza season in ambulatory and inpatient settings.
Researchers conducted a cohort study to assess the frequency at which environmental shedding of methicillin-resistant Staphylococcus aureus occurs during inpatient and outpatient appointments.
The purpose of the study was to compare a composite clinical failure outcome of 60-day readmission, 60-day recurrence, and mortality in patients treated for MRSA with dual therapy vs those de-escalated to monotherapy.
There is a low incidence of second PJI in patients with bacteremia or hematogenous periprosthetic joint infection with concomitant prosthetic implants.
Four medical societies have come together to publish an updated consensus guideline on dosing and monitoring vancomycin for the treatment of serious MRSA infections.
